CHARACTERIZATION OF TRISOMIC NATURAL KILLER CELL ABNORMALITIES IN A PATIENT WITH CONSTITUTIONAL TRISOMY 8 MOSAICISM

REFERENCES

• Karadima G, Bugge M, Nicolaidis P, et al. Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet 1998; 6: 432–438
   PubMed Web of Science ®Google Scholar
• Brady A F, Waters C S, Pocha M J, Brueton L A. Chronic myelomonocytic leukaemia in a child with constitutional partial trisomy 8 mosaicism. Clin Genet 2000; 58: 142–146
   Google Scholar
• Maserati E, April F, Viante F, et al. Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15–20% of cases. Genes Chromosomes Cancer 2002; 33: 93–97
   PubMed Web of Science ®Google Scholar
• Seghezzi L, Maserati E, Minelli A, et al. Constitutional trisomy 8 as first mutation in multistep carcinogenesis: clinical, cytogenetic, and molecular data on three cases. Genes Chromosomes Cancer 1996; 17: 94–101
   PubMed Web of Science ®Google Scholar
• Paulsson K, Heidenblad M, Strombeck B, et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 2006; 20: 840–846
   PubMed Web of Science ®Google Scholar
• Smyth M J, Dunn G P, Schreiber R D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006; 90: 1–50
   PubMed Web of Science ®Google Scholar
• Cooper M A, Fehniger T A, Caligiuri M A. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633–639
   PubMed Web of Science ®Google Scholar
• Orange J S. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002; 4: 1545–1558
   PubMed Web of Science ®Google Scholar
• Rubio G, Ferez X, Mora A, Galvez J, Chicano A, Garcia-Penarrubia P. Beta1 integrin triggering affects leukemic cell line sensitivity to natural killer cells. Cancer Immunol Immunother 2002; 51: 130–138
   Google Scholar
• Mark H FL. Constitutional mosaic trisomies, mutations, and deletions in cancer: a hypothesis. Cancer Genet Cytogenet 2000; 121: 103–105
   Google Scholar
• Kurtyka Z E, Krzykwa B, Piatkowska E, Radwan M, Pietrzyk J J. Trisomy 8 mosaicism syndrome: two cases demonstrating variability in phenotype. Clin Pediatr (Phila) 1988; 27: 557–564
   Google Scholar
• Ounap K, Bartsch O, Uibo O, Laidre P. Girl with combined cellular immunodeficiency, pancytopenia, malformations, deletion 11q23.3 –> qter, and trisomy 8q24.3 –> qter. Am J Med Genet 2002; 108: 322–326
   Google Scholar
• Engel B C, Podsakoff G M, Ireland J L, et al. Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Blood 2007; 109: 503–506
   PubMed Web of Science ®Google Scholar
• Biron C A, Byron K S, Sullivan J L. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320: 1731–1735
   PubMed Web of Science ®Google Scholar
• Kiladjian J J, Bourgeois E, Lobe I, et al. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia 2006; 20: 463–470
   PubMed Web of Science ®Google Scholar
• Raza A. Hypothesis: myelodysplastic syndromes may have a viral etiology. Int J Hematol 1998; 68: 245–256
   PubMed Web of Science ®Google Scholar
• Narendran A, Hawkins L M, Ganjavi H, et al. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome. Pediatr Hematol Oncol 2004; 21: 209–221
   PubMed Web of Science ®Google Scholar
• Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech Ageing Dev 1997; 96: 89–101
   Google Scholar
• Plackett T P, Boehmer E D, Faunce D E, Kovacs E J. Aging and innate immune cells. J Leukoc Biol 2004; 76: 291–299
   PubMed Web of Science ®Google Scholar
• Hakim F T, Flomerfelt F A, Boyiadzis M, Gress R E. Aging, immunity and cancer. Curr Opin Immunol 2004; 16: 151–156
   PubMed Web of Science ®Google Scholar
• Lutz C T, Moore M B, Bradley S, Shelton B J, Lutgendorf S K. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech. Ageing Dev 2005; 126: 722–731
   PubMed Web of Science ®Google Scholar
• Borrego F, Alonso M C, Galiani M D, Carracedo J, Ramirez R, Ostos B, Pena J, Solana R. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 1999; 34: 253–265
   PubMed Web of Science ®Google Scholar
• Matamoros N, Mila J, Llano M, Balas A, Vicario JL, Pons J, Crespi C, Martinez N, Iglesias-Alzueta J, Lopez-Botet M. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol 2001; 125: 274–282
   Google Scholar
• Farag S S, Caligiuri M A. Human natural killer cell development and biology. Blood Rev 2006; 20: 123–37
   PubMed Web of Science ®Google Scholar
• Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998; 161: 5821–5824
   PubMed Web of Science ®Google Scholar
• Schindowski K, Leutner S, Muller W E, Eckert A. Age-related changes of apoptotic cell death in human lymphocytes. Neurobiol Aging 2000; 21: 661–670
   PubMedGoogle Scholar
• Brando C, Mukhopadhyay S, Kovacs E, et al. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. J Leukoc Biol 2005; 78: 359–371
   Google Scholar
• Guarini A, Breccia M, Montefusco E, et al. Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission. Br J Haematol 2001; 113: 136–142
   PubMed Web of Science ®Google Scholar